PIROLA, ALESSANDRA
 Distribuzione geografica
Continente #
NA - Nord America 7.095
EU - Europa 3.369
AS - Asia 3.294
SA - Sud America 491
AF - Africa 77
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 7
Totale 14.348
Nazione #
US - Stati Uniti d'America 6.746
SG - Singapore 1.181
CN - Cina 750
IT - Italia 688
DE - Germania 659
VN - Vietnam 428
RU - Federazione Russa 414
SE - Svezia 400
BR - Brasile 366
HK - Hong Kong 364
IE - Irlanda 324
CA - Canada 293
GB - Regno Unito 208
UA - Ucraina 196
FR - Francia 169
IN - India 120
FI - Finlandia 81
TR - Turchia 69
BD - Bangladesh 63
AR - Argentina 46
IQ - Iraq 43
ID - Indonesia 41
KR - Corea 39
PL - Polonia 39
JP - Giappone 36
DK - Danimarca 34
ES - Italia 34
BE - Belgio 31
MX - Messico 30
ZA - Sudafrica 30
PK - Pakistan 27
NL - Olanda 24
CO - Colombia 18
SA - Arabia Saudita 18
AT - Austria 17
EC - Ecuador 17
PH - Filippine 15
VE - Venezuela 14
AU - Australia 13
UZ - Uzbekistan 13
CH - Svizzera 12
CL - Cile 10
JO - Giordania 10
KE - Kenya 10
LT - Lituania 10
IR - Iran 9
MA - Marocco 8
AE - Emirati Arabi Uniti 7
EU - Europa 7
NP - Nepal 7
OM - Oman 7
PE - Perù 7
PY - Paraguay 7
AZ - Azerbaigian 6
CZ - Repubblica Ceca 6
MY - Malesia 6
TN - Tunisia 6
DO - Repubblica Dominicana 5
EG - Egitto 5
ET - Etiopia 5
IL - Israele 5
PS - Palestinian Territory 5
TH - Thailandia 5
JM - Giamaica 4
LB - Libano 4
RO - Romania 4
UY - Uruguay 4
BG - Bulgaria 3
KG - Kirghizistan 3
LV - Lettonia 3
MU - Mauritius 3
NI - Nicaragua 3
AM - Armenia 2
BO - Bolivia 2
BW - Botswana 2
CR - Costa Rica 2
GR - Grecia 2
GT - Guatemala 2
HN - Honduras 2
LY - Libia 2
MG - Madagascar 2
NO - Norvegia 2
PA - Panama 2
RS - Serbia 2
SC - Seychelles 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BM - Bermuda 1
BS - Bahamas 1
CY - Cipro 1
DZ - Algeria 1
EE - Estonia 1
GE - Georgia 1
HU - Ungheria 1
KH - Cambogia 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
Totale 14.337
Città #
Ann Arbor 1.069
Singapore 692
Ashburn 655
Woodbridge 418
San Jose 382
Fairfield 378
Houston 354
Frankfurt am Main 350
Hong Kong 350
Chandler 347
Milan 317
Dublin 315
Wilmington 250
Dearborn 225
Toronto 184
Jacksonville 178
Seattle 171
New York 169
Los Angeles 148
Beijing 138
Cambridge 123
Ho Chi Minh City 118
Santa Clara 103
Hanoi 88
Princeton 86
Dallas 83
The Dalles 74
Chicago 72
Nanjing 65
Göttingen 61
Shanghai 58
Boardman 51
Lauterbourg 50
Munich 46
São Paulo 46
Buffalo 43
Altamura 37
Lawrence 36
Moscow 36
Seoul 34
Hefei 32
Jakarta 32
Orem 32
Brussels 31
Helsinki 31
Lachine 29
Ottawa 28
Rome 28
Nanchang 26
Shenyang 25
London 24
Warsaw 24
Council Bluffs 23
Dong Ket 23
Montreal 23
Da Nang 22
Guangzhou 22
San Diego 22
Fürstenwalde 21
Johannesburg 20
Tokyo 20
Andover 19
Fremont 19
Kocaeli 19
Baghdad 18
Chennai 18
Falls Church 17
Hebei 16
Nuremberg 16
Tianjin 16
Washington 16
Changsha 15
Denver 15
Stockholm 15
Brooklyn 14
Haiphong 14
Atlanta 13
Boston 13
Lissone 13
Manchester 13
Phoenix 13
Pune 13
Jiaxing 12
Jinan 12
Kunming 12
Mumbai 12
Turin 12
Ankara 11
Brasília 11
Edmonton 11
Lahore 11
Norwalk 11
Tashkent 11
Amman 10
Can Tho 10
Mexico City 10
Pavia 10
Rio de Janeiro 10
Riyadh 10
Salt Lake City 10
Totale 9.459
Nome #
De novo UBE2A mutations are recurrently acquired during chronic myeloid leukemia progression and interfere with myeloid differentiation pathways 615
A bioinformatics procedure to identify and annotate somatic mutations in whole-exome sequencing data 522
OncoScore: A novel, Internet-based tool to assess the oncogenic potential of genes 466
RNA-seq is a valuable complement of conventional diagnostic tools in newly diagnosed AML patients 456
Age and dPCR can predict relapse in CML patients who discontinued imatinib: The ISAV study 452
The Risk of Relapse in CML Patients Who Discontinued imatinib Can Be Predicted Based on Patients Age and the Results of dPCR Analysis 441
SETBP1 induces transcription of a network of development genes by acting as an epigenetic hub 422
Recurrent SETBP1 mutations in atypical chronic myeloid leukemia 410
WHOLE-EXOME SEQUENCING OF A PHILADELPHIA NEGATIVE CHRONIC MYELOID LEUKEMIA PATIENT THROUGH THE EXON-CAPTURE TECHNIQUE 399
A computational procedure to identify and annotate somatic mutations in next-generation sequencing data 399
Erratum: OncoScore: a novel, Internet-based tool to assess the oncogenic potential of genes 394
Synergistic activity of ALK and mTOR inhibitors for the treatment of NPM-ALK positive lymphoma 384
Integrated Genomic, Functional, and Prognostic Characterization of Atypical Chronic Myeloid Leukemia 384
Recurrent ETNK1 mutations in atypical chronic myeloid leukemia 378
Concomitant BCORL1 and BRAF Mutations in Vemurafenib-Resistant Melanoma Cells 367
Evidence of ETNK1 Somatic Variants in Atypical Chronic Myeloid Leukemia 347
Whole-Exome Sequencing Data - Identifying Somatic Mutations 346
Treatment efficacy and resistance mechanisms using the second-generation ALK inhibitor AP26113 in human NPM-ALK-positive anaplastic large cell lymphoma 336
Identification of novel point mutations in splicing sites integrating whole-exome and RNA-seq data in myeloproliferative diseases 330
Oncoscore, a Novel, Internet-Based Tool to Assess the Oncogenic Potential of Genes Can Differentiate Between CP-CML and BC-CML Associated Genes, and Between CP-CML Patients with Good and Bad Prognosis 329
CEQer: A Graphical Tool for Copy Number and Allelic Imbalance Detection from Whole-Exome Sequencing Data 318
Gene expression signature of non-involved lung tissue associated with survival in lung adenocarcinoma patients 313
Integrated Analysis of Whole-Exome Sequencing and Micrornas Expression in Blast Crisis Transformation of Chronic Myeloid Leukemia 311
Recurrent SETBP1 Mutations in Atypical Chronic Myeloid Leukemia 307
BCR and BCR-ABL regulation during myeloid differentiation in healthy donors and in chronic phase/blast crisis CML patients 304
Read-through transcripts in normal human lung parenchyma are down-regulated in lung adenocarcinoma 304
ETNK1 is an early event and SETBP1 a late event in atypical Chronic Myeloid Leukemia 293
Recurrent somatic mutations of FAT family cadherins induce an aggressive phenotype and poor prognosis in anaplastic large cell lymphoma 292
Identification of a Novel Splicing Mutation in Blast Crisis Transformation of Chronic Myeloid Leukemia Integrating Whole-exome and RNA-Seq data 285
CML Patients Present Additional Mutations in Cancer Related Genes When Tested At Diagnosis 283
FusionAnalyser: a new graphical, event-driven tool for fusion rearrangements discovery 279
Recurrent KIT D816V Mutation in Atypical Chronic Myeloid Leukemia 276
Synergistic activity of the Src/Abl inhibitor bosutinib in combination with imatinib 266
Clonal evolution analysis identifies ETNK1 as an early event and SETBP1 as a late event in atypical Chronic Myeloid Leukemia 264
Whole-exome sequencing of matched chronic phase and blast crisis CML samples to reveal mechanisms of blast crisis transformation 256
Identification of Novel Point Mutations in Splicing Sites by the Integration of Exome and RNA Sequencing Data in Myeloproliferative Diseases 254
Whole-Exome Sequencing of 8 Atypical Chronic Myeloid Leukaemia Patients 248
Abstract 3583: Drug-resistant NPM/ALK mutants show different sensitivity to second generation tyrosine kinase inhibitors 245
BCR AND BCR-ABL REGULATION DURING MYELOID DIFFERENTIATION IN HEALTHY DONORS AND CHRONIC PHASE-BLAST CRISIS CML PATIENTS 239
NPM/ALK mutants resistant to ASP3026 display variable sensitivity to alternative ALK inhibitors but succumb to the novel compound PF-06463922 235
Synergistic Activity of ALK and mTOR Inhibitors for the Treatment of NPM-ALK Positive Lymphoma 227
Erratum: Treatment efficacy and resistance mechanisms using the second-generation ALK inhibitor AP26113 in human NPM-ALK-positive anaplastic large cell lymphoma (Molecular Cancer Research (2015) 13 (775-783)) 206
Gut virome-colonising Orthohepadnavirus genus is associated with ulcerative colitis pathogenesis and induces intestinal inflammation in vivo 206
Identification of genetic polymorphisms modulating nausea and vomiting in two series of opioid-treated cancer patients 196
Mechanisms of resistance to the second-generation ALK inhibitor AP26113 in human NPM-ALK-positive anaplastic large cell lymphoma cells 157
Totale 14.741
Categoria #
all - tutte 43.701
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.701


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022637 47 70 75 52 32 61 36 33 33 64 51 83
2022/20231.330 143 400 129 128 104 196 12 76 79 17 28 18
2023/2024886 27 35 34 53 110 270 176 12 49 25 8 87
2024/20251.919 135 166 120 97 194 74 113 72 164 360 161 263
2025/20265.081 610 209 387 595 622 251 761 173 408 478 304 283
2026/20277 7 0 0 0 0 0 0 0 0 0 0 0
Totale 14.741